


|
GEDRI Project: 06883-04 TRANSGENIC MODELS OF DIOXIN ACTION
0. Country: United States
1. Sponsor Organization: NIH/NIEHS
2. Project Title: 06883-04 TRANSGENIC MODELS OF DIOXIN ACTION
3. Project Focus:
- Project Primary Focus: Human Health Effects
- Project Secondary Focus:
4. Description:
Over the last two years, we have cloned the AHR cDNA and found that it contains a basic-region/helix-loop-helix domain similar to that found in its dimerization partner ARNT. More recently, our mutagenesis studies have provided a functional map of the AHR and have allowed us to localize those domains required for DNA binding, agonist binding, dimerization and transcriptional activation. In addition, we have cloned and characterized the AHR's structural gene, identified many of the 5' regulatory elements that control its expression and mapped its chromosomal location in mice and humans. In this application, we propose to use this new information and the related molecular probes to identify those developmental stages most sensitive to TCDD-toxicity and to construct transgenic mouse lines with mutant and controllable Ahr- and Arnt-loci. One of our highest priorities will be directed towards development of a targeting vector for use in "knocking-out" the AHR and ARNT in embryonic stem cells (Bs cells). By injecting these recombinant Es cells into blastocysts, we propose to generate transgenic mice which are heterozygous and homozygous for a null mutation at the Ahr- and Amt-loci. We propose that the mouse strains gene rated under this project will prove valuable in the following ways, 1) to determine the phenotype of mice lacking an AHR or ARNT, 2) to identify the effects of TCDD and PCB mixtures that are not mediated by the AHR or ARNT, 3) as prototype strains for subsequent in vivo mutation studies of the Ahr- and Arnt-loci (e.g. humanizing the murine model), and 4) determining the role of altered gene expression in TCDD toxicity.
5. References:
6. Inventory Category:
- Primary: Models
- Secondary:
7. Inventory Subcategory:
- Primary: Basic Research
- Secondary:
8. Keywords for Experimental System/Species:
- Species:
- Study Type:
- In Vitro
- Laboratory Study
- Fate and Transport:
9. Keywords for Experimental Endpoints:
- Health Effect:
- Hormonal Measures:
- Level Of Study:
- Transgenic Model, Ah Receptor
- Chemistry Metabolism:
- Life Stage:
- Risk Assessment:
10. Chemical Agents:
11. Performing Institution:
12. Contact:
Edit
(password needed)
Return to the Endocrine Disruptors Research Initiative Home Page.
|